Sato, Tomoo <br/><br/>
Mogamulizumab (Anti-CCR4) in HTLV-1-Associated Myelopathy.  [electronic resource] 

 -  The New England journal of medicine  02 2018 
 - 529-538 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1533-4406 
<br/><br/><label>Standard No.: </label>10.1056/NEJMoa1704827  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Area Under Curve<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Exanthema--chemically induced<br/>Female<br/>Human T-lymphotropic virus 1--isolation & purification<br/>Humans<br/>Male<br/>Middle Aged<br/>Paraparesis, Tropical Spastic--drug therapy<br/>Receptors, CCR4--antagonists & inhibitors<br/>T-Lymphocytes--immunology<br/>Viral Load